Navigation Links
DecisionView Board of Directors Appoints James P. Scullion as CEO and President

High Tech Industry Veteran Will Focus on Broader Product Distribution, Revenue Growth and Profitability

SAN FRANCISCO, March 31 /PRNewswire/ -- DecisionView, Inc., the leading provider of Clinical Optimization Solutions for the Life Sciences industry, today announced that its Board of Directors has appointed James P. Scullion to the role of Chairman, President and CEO of DecisionView, effective immediately. Most recently, he held the role of Chairman for DecisionView. Scullion succeeds Steve Andrade as the Company's President and Chief Executive Officer.

"I'm very pleased that Jim has agreed to join DecisionView as its new CEO," said Chris Hollenbeck, a DecisionView Board Member. "We believe the market for clinical optimization solutions is poised for significant growth. Jim has over two decades of experience leading high tech companies, and his expertise will greatly benefit DecisionView as the company looks to extend its leadership position as a comprehensive provider of business performance optimization applications."

Mr. Scullion brings more than 20 years of experience as a "C" level executive in the high technology industry to his new position. Most recently, he served as Chairman and CEO of Tumbleweed Communications from January 2006 to September 2008. Under Mr. Scullion's leadership, Tumbleweed was successfully transformed from an email security centric company to a leading provider of secure content delivery solutions to Global 1000 and midmarket enterprises doubling its customer base from 1,700 to 3,500 customers. Tumbleweed was acquired by Sopra Group in September 2008. From January 2004 to January 2006, he was CEO of ComnetiX, Inc., a leading provider of criminal intelligence systems. During Mr. Scullion's tenure at ComnetiX, revenues grew threefold and he led the company's successful IPO on the Toronto Stock Exchange. From 1990 to 2002, he held senior management positions including President and COO with Identix Incorporated, a publicly traded biometric technology company. While at Identix, Scullion led the company's growth in annual revenues from $1 million to more than $80 million.

"DecisionView is the technology leader in the clinical recruitment optimization market," said Scullion. "I am excited to be joining a company that is well positioned to capitalize on a fast growing, high demand market. I believe my leadership and operational experience will further strengthen the already outstanding DecisionView team, and will help accelerate our company's growth as we expand and enrich our optimization solutions for the Life Sciences industry."

Steve Andrade will be leaving the company to pursue other interests and will also be stepping down from his position as a member of the DecisionView board of directors.

About DecisionView, Inc.

DecisionView develops innovative software solutions that optimize the clinical performance of life sciences organizations around the world. By uniquely converging predictive analytics, simulation, visualization and data aggregation capabilities into functionally rich and easy to use applications, the company's solutions deliver proven business value in faster cycle times, reducing clinical costs and improving clinical productivity. To learn more, visit

SOURCE DecisionView, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DecisionView Unveils the Next Generation of Clinical Trial Software: StudyOptimizer 4.0
2. Andrew Dallas, President of Full Spectrum Software Appointed to Medical Device and Diagnostic Industry Magazine Editorial Advisory Board
3. Nutrition 21s President and CEO, Elected to the Consumer Healthcare Products Association Board
4. Ingenious Med Expands Leadership and Adds Members to Board of Directors
5. AORN and Mercy Ships Collaborate to Increase Patient Care Aboard Hospital Ships
6. Loop Joins Board of Management Health Solutions, Inc.
7. Gen-Probe Board of Directors Elects Carl Hull Chief Executive Officer
8. TrinityCare Appoints Kirk B. Shulke, M.D. to Board of Directors
9. RiskMetrics Affirms Recommendation that Stockholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group
10. TrinityCare Appoints Decorated Christian Artist Al Denson to Board of Directors
11. Former Merck Executive Joins Board of Clinical Information Network, Inc.
Post Your Comments:
(Date:11/24/2015)... ALEXANDRIA, VA (PRWEB) , ... November 24, 2015 ... ... encourages people across the United States to support their local poison centers through ... been designated as #GivingTuesday: calls it “a day that inspires people to ...
(Date:11/24/2015)... Marne, MI (PRWEB) , ... November 24, 2015 , ... ... has released a series of recent video interviews with some of the staff members ... life at the residential treatment facility, as well as some of the things that ...
(Date:11/24/2015)... ... ... Aided by seed funding from the Ron Foley Foundation, researchers at Western ... how to detect and treat pancreatic cancer (PC). , WCHN researchers will focus ... (ncRNA), genetic material that is present in the blood of patients with PC. ...
(Date:11/24/2015)... ... November 24, 2015 , ... Abington Hospital – Jefferson ... of Quality® Bariatric Surgery Facility for treating individuals living with morbid or extreme ... services available to its members to help them make informed decisions about their ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Rodney E. Willey , has answered a ... Koala Center for Sleep Disorders, provides treatment for snoring and sleep apnea through ... a Koala Center for Sleep Disorders in the US, one of four in the Illinois ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , November 24, 2015 --> ... report "Spine Biologics Market by Product Type (Bone Graft, Bine ... Discectomy and Fusion, Posterior Lumbar Interbody Fusion), End User, and ... global market was valued at $1.90 Billion in 2014 and ... CAGR of 4.4% during the forecast period of 2015 to ...
(Date:11/24/2015)... LAUSANNE and BERN, Switzerland ... SA, the ARTORG Center for Biomedical Engineering Research of ... and the Division of Endocrinology, Diabetes and Clinical Nutrition ... announce the start of an exclusive collaboration to develop ... control algorithm for the personalised delivery of insulin for ...
(Date:11/24/2015)... st  Scientific Assembly and Annual Meeting of the Radiological Society ... Chicago on Nov-29 th through Dec-4 ...  Scientific Assembly and Annual Meeting of the Radiological Society of ... Chicago on Nov-29 th through Dec-4 th , ... present its revolutionary whole body CZT digital SPECT/CT solution at the ...
Breaking Medicine Technology: